APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

GnRH Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GnRH Receptor Antagonists Industry Growth and Trends Forecast to 2032

Report ID 17399603012 January 202693 pages

Choose your research edition.

Industry ResearchGnRH Receptor Antagonists Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal GnRH Receptor Antagonists Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal GnRH Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GnRH Receptor Antagonists Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal GnRH Receptor Antagonists Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global GnRH Receptor Antagonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GnRH Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GnRH Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GnRH Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GnRH Receptor Antagonists include Ferring Pharmaceuticals, Kissei, Myovant Sciences, Veru Inc, AstraZeneca, AbbVie, Astellas, Jiangsu Hengrui Medicine Co and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GnRH Receptor Antagonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GnRH Receptor Antagonists market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GnRH Receptor Antagonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GnRH Receptor Antagonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GnRH Receptor Antagonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GnRH Receptor Antagonists Market by Company

Ferring Pharmaceuticals

Kissei

Myovant Sciences

Veru Inc

AstraZeneca

AbbVie

Astellas

Jiangsu Hengrui Medicine Co

Takeda

GnRH Receptor Antagonists Segment by Type

Peptides

Small Molecules

GnRH Receptor Antagonists Segment by Application

Endometriosis

Uterine Fibroids

Prostate Cancer

Female Infertility

Others

GnRH Receptor Antagonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GnRH Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GnRH Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GnRH Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GnRH Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GnRH Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Peptides Table 2. Major Company of Small Molecules Table 3. Global GnRH Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global GnRH Receptor Antagonists Sales by Type (2021-2026) & (W Units) Table 5. Global GnRH Receptor Antagonists Sales Market Share in Volume by Type (2021-2026) Table 6. Global GnRH Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 7. Global GnRH Receptor Antagonists Sales Market Share in Value by Type (2021-2026) Table 8. Global GnRH Receptor Antagonists Price by Type (2021-2026) & (US$/Unit) Table 9. Global GnRH Receptor Antagonists Sales by Type (2027-2032) & (W Units) Table 10. Global GnRH Receptor Antagonists Sales Market Share in Volume by Type (2027-2032) Table 11. Global GnRH Receptor Antagonists Sales by Type (2027-2032) & (US$ Million) Table 12. Global GnRH Receptor Antagonists Sales Market Share in Value by Type (2027-2032) Table 13. Global GnRH Receptor Antagonists Price by Type (2027-2032) & (US$/Unit) Table 14. North America GnRH Receptor Antagonists Sales by Type (2021-2026) & (W Units) Table 15. North America GnRH Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 16. Europe GnRH Receptor Antagonists Sales by Type (2021-2026) & (W Units) Table 17. Europe GnRH Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific GnRH Receptor Antagonists Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific GnRH Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America GnRH Receptor Antagonists Sales by Type (2021-2026) & (W Units) Table 21. Latin America GnRH Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa GnRH Receptor Antagonists Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa GnRH Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 24. GnRH Receptor Antagonists Industry Trends Table 25. GnRH Receptor Antagonists Industry Drivers Table 26. GnRH Receptor Antagonists Industry Opportunities and Challenges Table 27. GnRH Receptor Antagonists Industry Restraints Table 28. Global GnRH Receptor Antagonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global GnRH Receptor Antagonists Revenue Market Share by Company (2021-2026) Table 30. Global GnRH Receptor Antagonists Sales by Company (2021-2026) & (W Units) Table 31. Global GnRH Receptor Antagonists Sales Share by Company (2021-2026) Table 32. Global GnRH Receptor Antagonists Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global GnRH Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global GnRH Receptor Antagonists Major Company Production Sites and Headquarters Table 35. Global GnRH Receptor Antagonists Company, Product Type & Application Table 36. Global GnRH Receptor Antagonists Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global GnRH Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global GnRH Receptor Antagonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global GnRH Receptor Antagonists Sales by Region (2021-2026) & (W Units) Table 41. Global GnRH Receptor Antagonists Sales Market Share in Volume by Region (2021-2026) Table 42. Global GnRH Receptor Antagonists Sales by Region (2021-2026) & (US$ Million) Table 43. Global GnRH Receptor Antagonists Sales Market Share in Value by Region (2021-2026) Table 44. Global GnRH Receptor Antagonists Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global GnRH Receptor Antagonists Sales by Region (2027-2032) & (W Units) Table 46. Global GnRH Receptor Antagonists Sales Market Share in Volume by Region (2027-2032) Table 47. Global GnRH Receptor Antagonists Sales by Region (2027-2032) & (US$ Million) Table 48. Global GnRH Receptor Antagonists Sales Market Share in Value by Region (2027-2032) Table 49. Global GnRH Receptor Antagonists Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global GnRH Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global GnRH Receptor Antagonists Sales by Application (2021-2026) & (W Units) Table 52. Global GnRH Receptor Antagonists Sales Market Share in Volume by Application (2021-2026) Table 53. Global GnRH Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 54. Global GnRH Receptor Antagonists Sales Market Share in Value by Application (2021-2026) Table 55. Global GnRH Receptor Antagonists Price by Application (2021-2026) & (US$/Unit) Table 56. Global GnRH Receptor Antagonists Sales by Application (2027-2032) & (W Units) Table 57. Global GnRH Receptor Antagonists Sales Market Share in Volume by Application (2027-2032) Table 58. Global GnRH Receptor Antagonists Sales by Application (2027-2032) & (US$ Million) Table 59. Global GnRH Receptor Antagonists Sales Market Share in Value by Application (2027-2032) Table 60. Global GnRH Receptor Antagonists Price by Application (2027-2032) & (US$/Unit) Table 61. North America GnRH Receptor Antagonists Sales by Application (2021-2026) & (W Units) Table 62. North America GnRH Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 63. Europe GnRH Receptor Antagonists Sales by Application (2021-2026) & (W Units) Table 64. Europe GnRH Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific GnRH Receptor Antagonists Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific GnRH Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America GnRH Receptor Antagonists Sales by Application (2021-2026) & (W Units) Table 68. Latin America GnRH Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa GnRH Receptor Antagonists Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa GnRH Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 71. Ferring Pharmaceuticals Company Information Table 72. Ferring Pharmaceuticals Business Overview Table 73. Ferring Pharmaceuticals GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Ferring Pharmaceuticals GnRH Receptor Antagonists Product Portfolio Table 75. Ferring Pharmaceuticals Recent Development Table 76. Kissei Company Information Table 77. Kissei Business Overview Table 78. Kissei GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Kissei GnRH Receptor Antagonists Product Portfolio Table 80. Kissei Recent Development Table 81. Myovant Sciences Company Information Table 82. Myovant Sciences Business Overview Table 83. Myovant Sciences GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Myovant Sciences GnRH Receptor Antagonists Product Portfolio Table 85. Myovant Sciences Recent Development Table 86. Veru Inc Company Information Table 87. Veru Inc Business Overview Table 88. Veru Inc GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Veru Inc GnRH Receptor Antagonists Product Portfolio Table 90. Veru Inc Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AstraZeneca GnRH Receptor Antagonists Product Portfolio Table 95. AstraZeneca Recent Development Table 96. AbbVie Company Information Table 97. AbbVie Business Overview Table 98. AbbVie GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. AbbVie GnRH Receptor Antagonists Product Portfolio Table 100. AbbVie Recent Development Table 101. Astellas Company Information Table 102. Astellas Business Overview Table 103. Astellas GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Astellas GnRH Receptor Antagonists Product Portfolio Table 105. Astellas Recent Development Table 106. Jiangsu Hengrui Medicine Co Company Information Table 107. Jiangsu Hengrui Medicine Co Business Overview Table 108. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product Portfolio Table 110. Jiangsu Hengrui Medicine Co Recent Development Table 111. Takeda Company Information Table 112. Takeda Business Overview Table 113. Takeda GnRH Receptor Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Takeda GnRH Receptor Antagonists Product Portfolio Table 115. Takeda Recent Development Table 116. North America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 117. North America GnRH Receptor Antagonists Sales by Country (2021-2026) & (W Units) Table 118. North America GnRH Receptor Antagonists Sales Market Share by Country (2021-2026) Table 119. North America GnRH Receptor Antagonists Sales Forecast by Country (2027-2032) & (W Units) Table 120. North America GnRH Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 121. North America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America GnRH Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 123. North America GnRH Receptor Antagonists Market Share by Country (2021-2026) Table 124. North America GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America GnRH Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 126. Europe GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. Europe GnRH Receptor Antagonists Sales by Country (2021-2026) & (W Units) Table 128. Europe GnRH Receptor Antagonists Sales Market Share by Country (2021-2026) Table 129. Europe GnRH Receptor Antagonists Sales Forecast by Country (2027-2032) & (W Units) Table 130. Europe GnRH Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 131. Europe GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe GnRH Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe GnRH Receptor Antagonists Market Share by Country (2021-2026) Table 134. Europe GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe GnRH Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific GnRH Receptor Antagonists Sales by Country (2021-2026) & (W Units) Table 138. Asia-Pacific GnRH Receptor Antagonists Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific GnRH Receptor Antagonists Sales Forecast by Country (2027-2032) & (W Units) Table 140. Asia-Pacific GnRH Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific GnRH Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific GnRH Receptor Antagonists Market Share by Country (2021-2026) Table 144. Asia-Pacific GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific GnRH Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 146. Latin America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Latin America GnRH Receptor Antagonists Sales by Country (2021-2026) & (W Units) Table 148. Latin America GnRH Receptor Antagonists Sales Market Share by Country (2021-2026) Table 149. Latin America GnRH Receptor Antagonists Sales Forecast by Country (2027-2032) & (W Units) Table 150. Latin America GnRH Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America GnRH Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America GnRH Receptor Antagonists Market Share by Country (2021-2026) Table 154. Latin America GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America GnRH Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa GnRH Receptor Antagonists Sales by Country (2021-2026) & (W Units) Table 158. Middle East and Africa GnRH Receptor Antagonists Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa GnRH Receptor Antagonists Sales Forecast by Country (2027-2032) & (W Units) Table 160. Middle East and Africa GnRH Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa GnRH Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa GnRH Receptor Antagonists Market Share by Country (2021-2026) Table 164. Middle East and Africa GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa GnRH Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. GnRH Receptor Antagonists Distributors List Table 169. GnRH Receptor Antagonists Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. GnRH Receptor Antagonists Image Figure 2. Global GnRH Receptor Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GnRH Receptor Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global GnRH Receptor Antagonists Sales (2021-2032) & (W Units) Figure 5. Peptides Image Figure 6. Global Peptides Sales YoY Growth (2021-2032) & (W Units) Figure 7. Small Molecules Image Figure 8. Global Small Molecules Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global GnRH Receptor Antagonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global GnRH Receptor Antagonists Market Share by Type 2025 VS 2032 Figure 11. North America GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 12. North America GnRH Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 13. Europe GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 14. Europe GnRH Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 17. Latin America GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 18. Latin America GnRH Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 GnRH Receptor Antagonists Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Endometriosis Image Figure 24. Global Endometriosis Sales YoY Growth (2021-2032) & (W Units) Figure 25. Uterine Fibroids Image Figure 26. Global Uterine Fibroids Sales YoY Growth (2021-2032) & (W Units) Figure 27. Prostate Cancer Image Figure 28. Global Prostate Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 29. Female Infertility Image Figure 30. Global Female Infertility Sales YoY Growth (2021-2032) & (W Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 33. Global GnRH Receptor Antagonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global GnRH Receptor Antagonists Market Share by Application 2025 VS 2032 Figure 35. North America GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 36. North America GnRH Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 37. Europe GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 38. Europe GnRH Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific GnRH Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 41. Latin America GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 42. Latin America GnRH Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa GnRH Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 45. North America GnRH Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. North America GnRH Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America GnRH Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America GnRH Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe GnRH Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Europe GnRH Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe GnRH Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe GnRH Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific GnRH Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Asia-Pacific GnRH Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific GnRH Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific GnRH Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America GnRH Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Latin America GnRH Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America GnRH Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America GnRH Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa GnRH Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Middle East and Africa GnRH Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa GnRH Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa GnRH Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. GnRH Receptor Antagonists Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. GnRH Receptor Antagonists Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Peptides
  • Small Molecules
Applications
  • Endometriosis
  • Uterine Fibroids
  • Prostate Cancer
  • Female Infertility
  • Others
Companies covered
  • Ferring Pharmaceuticals
  • Kissei
  • Myovant Sciences
  • Veru Inc
  • AstraZeneca
  • AbbVie
  • Astellas
  • Jiangsu Hengrui Medicine Co
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GnRH Receptor Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GnRH Receptor Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GnRH Receptor Antagonists Market by Type
  6. 1.3.1 Peptides
  7. 1.3.2 Small Molecules
  8. 1.4 Global GnRH Receptor Antagonists Market Size by Type
  9. 1.4.1 Global GnRH Receptor Antagonists Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global GnRH Receptor Antagonists Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global GnRH Receptor Antagonists Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America GnRH Receptor Antagonists Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe GnRH Receptor Antagonists Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific GnRH Receptor Antagonists Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America GnRH Receptor Antagonists Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa GnRH Receptor Antagonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GnRH Receptor Antagonists Industry Trends
  2. 2.2 GnRH Receptor Antagonists Industry Drivers
  3. 2.3 GnRH Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 GnRH Receptor Antagonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GnRH Receptor Antagonists Revenue (2021-2026)
  2. 3.2 Global Top Players by GnRH Receptor Antagonists Sales (2021-2026)
  3. 3.3 Global Top Players by GnRH Receptor Antagonists Price (2021-2026)
  4. 3.4 Global GnRH Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GnRH Receptor Antagonists Major Company Production Sites & Headquarters
  6. 3.6 Global GnRH Receptor Antagonists Company, Product Type & Application
  7. 3.7 Global GnRH Receptor Antagonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GnRH Receptor Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GnRH Receptor Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GnRH Receptor Antagonists Tier 1, Tier 2, and Tier 3
4 GnRH Receptor Antagonists Regional Status and Outlook
  1. 4.1 Global GnRH Receptor Antagonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GnRH Receptor Antagonists Historic Market Size by Region
  3. 4.2.1 Global GnRH Receptor Antagonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GnRH Receptor Antagonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GnRH Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GnRH Receptor Antagonists Forecasted Market Size by Region
  7. 4.3.1 Global GnRH Receptor Antagonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GnRH Receptor Antagonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GnRH Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GnRH Receptor Antagonists by Application
  1. 5.1 GnRH Receptor Antagonists Market by Application
  2. 5.1.1 Endometriosis
  3. 5.1.2 Uterine Fibroids
  4. 5.1.3 Prostate Cancer
  5. 5.1.4 Female Infertility
  6. 5.1.5 Others
  7. 5.2 Global GnRH Receptor Antagonists Market Size by Application
  8. 5.2.1 Global GnRH Receptor Antagonists Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global GnRH Receptor Antagonists Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global GnRH Receptor Antagonists Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America GnRH Receptor Antagonists Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe GnRH Receptor Antagonists Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific GnRH Receptor Antagonists Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America GnRH Receptor Antagonists Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa GnRH Receptor Antagonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ferring Pharmaceuticals
  2. 6.1.1 Ferring Pharmaceuticals Company Information
  3. 6.1.2 Ferring Pharmaceuticals Business Overview
  4. 6.1.3 Ferring Pharmaceuticals GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ferring Pharmaceuticals GnRH Receptor Antagonists Product Portfolio
  6. 6.1.5 Ferring Pharmaceuticals Recent Developments
  7. 6.2 Kissei
  8. 6.2.1 Kissei Company Information
  9. 6.2.2 Kissei Business Overview
  10. 6.2.3 Kissei GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kissei GnRH Receptor Antagonists Product Portfolio
  12. 6.2.5 Kissei Recent Developments
  13. 6.3 Myovant Sciences
  14. 6.3.1 Myovant Sciences Company Information
  15. 6.3.2 Myovant Sciences Business Overview
  16. 6.3.3 Myovant Sciences GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Myovant Sciences GnRH Receptor Antagonists Product Portfolio
  18. 6.3.5 Myovant Sciences Recent Developments
  19. 6.4 Veru Inc
  20. 6.4.1 Veru Inc Company Information
  21. 6.4.2 Veru Inc Business Overview
  22. 6.4.3 Veru Inc GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Veru Inc GnRH Receptor Antagonists Product Portfolio
  24. 6.4.5 Veru Inc Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca GnRH Receptor Antagonists Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie GnRH Receptor Antagonists Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Astellas
  38. 6.7.1 Astellas Company Information
  39. 6.7.2 Astellas Business Overview
  40. 6.7.3 Astellas GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Astellas GnRH Receptor Antagonists Product Portfolio
  42. 6.7.5 Astellas Recent Developments
  43. 6.8 Jiangsu Hengrui Medicine Co
  44. 6.8.1 Jiangsu Hengrui Medicine Co Company Information
  45. 6.8.2 Jiangsu Hengrui Medicine Co Business Overview
  46. 6.8.3 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product Portfolio
  48. 6.8.5 Jiangsu Hengrui Medicine Co Recent Developments
  49. 6.9 Takeda
  50. 6.9.1 Takeda Company Information
  51. 6.9.2 Takeda Business Overview
  52. 6.9.3 Takeda GnRH Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Takeda GnRH Receptor Antagonists Product Portfolio
  54. 6.9.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America GnRH Receptor Antagonists Sales by Country
  2. 7.1.1 North America GnRH Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GnRH Receptor Antagonists Sales by Country (2021-2026)
  4. 7.1.3 North America GnRH Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America GnRH Receptor Antagonists Market Size by Country
  6. 7.2.1 North America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GnRH Receptor Antagonists Market Size by Country (2021-2026)
  8. 7.2.3 North America GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GnRH Receptor Antagonists Sales by Country
  2. 8.1.1 Europe GnRH Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GnRH Receptor Antagonists Sales by Country (2021-2026)
  4. 8.1.3 Europe GnRH Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GnRH Receptor Antagonists Market Size by Country
  6. 8.2.1 Europe GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GnRH Receptor Antagonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GnRH Receptor Antagonists Sales by Country
  2. 9.1.1 Asia-Pacific GnRH Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GnRH Receptor Antagonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GnRH Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GnRH Receptor Antagonists Market Size by Country
  6. 9.2.1 Asia-Pacific GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GnRH Receptor Antagonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GnRH Receptor Antagonists Sales by Country
  2. 10.1.1 South America GnRH Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GnRH Receptor Antagonists Sales by Country (2021-2026)
  4. 10.1.3 South America GnRH Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America GnRH Receptor Antagonists Market Size by Country
  6. 10.2.1 South America GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GnRH Receptor Antagonists Market Size by Country (2021-2026)
  8. 10.2.3 South America GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GnRH Receptor Antagonists Sales by Country
  2. 11.1.1 Middle East and Africa GnRH Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GnRH Receptor Antagonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GnRH Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GnRH Receptor Antagonists Market Size by Country
  6. 11.2.1 Middle East and Africa GnRH Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GnRH Receptor Antagonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GnRH Receptor Antagonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GnRH Receptor Antagonists Value Chain Analysis
  2. 12.1.1 GnRH Receptor Antagonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GnRH Receptor Antagonists Production Mode & Process
  7. 12.2 GnRH Receptor Antagonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GnRH Receptor Antagonists Distributors
  10. 12.2.3 GnRH Receptor Antagonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst